The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - Antioxidants, 2021 - mdpi.com
… Using online databases, we carried out a systematic literature review of the treatments for
COVID-19 which was restricted to clinical studies. The key articles were retrieved from …
COVID-19 which was restricted to clinical studies. The key articles were retrieved from …
Effectiveness of SARS-CoV-2 vaccines for short-and long-term immunity: a general overview for the pandemic contrast
AD Inchingolo, G Malcangi, S Ceci, A Patano… - International Journal of …, 2022 - mdpi.com
… literature overview was produced in order to evaluate the state-of-art in SARS-CoV-2 diagnoses,
prognoses, therapies… SARS-CoV-2 virus and aluminum hydroxide for adjuvants (Table 5…
prognoses, therapies… SARS-CoV-2 virus and aluminum hydroxide for adjuvants (Table 5…
COVID-19 infection in children and infants: Current status on therapies and vaccines
G Malcangi, AD Inchingolo, AM Inchingolo, F Piras… - Children, 2022 - mdpi.com
… SiTIP) performed a literature review on recommended treatments in children with … SARS-CoV-2
infections have a favorable course in children, so drug treatment without adjuvant therapy …
infections have a favorable course in children, so drug treatment without adjuvant therapy …
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
M Bellucci, FM Bozzano, C Castellano… - Frontiers in …, 2024 - frontiersin.org
… In October 2021, a 60-year-old male was admitted to the ER for dyspnea due to COVID-19
interstitial pneumonia and treated with high-flow oxygen therapy. Then, 20 days after testing …
interstitial pneumonia and treated with high-flow oxygen therapy. Then, 20 days after testing …
[引用][C] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants.
IA Danilo - 2021 - openrepository.ru
The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and
Adjuvants. - «Национальный агрегатор открытых репозиториев российских …
Adjuvants. - «Национальный агрегатор открытых репозиториев российских …
COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies
G Malcangi, AD Inchingolo, AM Inchingolo… - Microorganisms, 2021 - mdpi.com
… : a literature overview was performed including clinical trials, in vitro studies, reviews and …
recent insights and the effectiveness of therapies for SARS-CoV-2 infection in children, infants …
recent insights and the effectiveness of therapies for SARS-CoV-2 infection in children, infants …
[HTML][HTML] … of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2
A Livieratos, LE Schiro, C Gogos, K Akinosoglou - Vaccines, 2024 - mdpi.com
… This study performed a literature review to assess the … individuals, but often require adjuvants
and repeated doses to … influenza immunity extending beyond 15 months, with a minority …
and repeated doses to … influenza immunity extending beyond 15 months, with a minority …
Corneal adverse events associated with SARS-CoV-2/COVID-19 vaccination: a systematic review
… Treatment with topical dexamethasone/tobramycin and … an immune reaction to vaccination
adjuvants, which are used to … /intraocular lens implantation 15 months and 3.5 years after the …
adjuvants, which are used to … /intraocular lens implantation 15 months and 3.5 years after the …
Inflammation as prognostic hallmark of clinical outcome in patients with SARS-CoV-2 infection
D Fuzio, AM Inchingolo, V Ruggieri, M Fasano… - Life, 2023 - mdpi.com
… of positive cases and vaccines, to adjuvant therapies and specific antiviral treatments [7,8,9].
Due to the extreme variety of the spectrum of clinical manifestations of COVID-19, it is …
Due to the extreme variety of the spectrum of clinical manifestations of COVID-19, it is …
Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: a systematic review
EE Tsermpini, U Glamočlija, F Ulucan-Karnak… - Antioxidants, 2022 - mdpi.com
… in hospitalized SARS-CoV-2 positive compared to SARS-CoV-2 … Vitamin therapy was not
suggested to replace classical … treatments for COVID-19, but it could be used as an adjuvant …
suggested to replace classical … treatments for COVID-19, but it could be used as an adjuvant …